A detailed history of Leverty Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Leverty Financial Group, LLC holds 1,026 shares of LLY stock, worth $746,107. This represents 0.5% of its overall portfolio holdings.

Number of Shares
1,026
Holding current value
$746,107
% of portfolio
0.5%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$772.14 - $960.02 $792,215 - $984,980
1,026 New
1,026 $908,000
Q1 2022

Apr 20, 2022

SELL
$234.69 - $291.66 $24,877 - $30,915
-106 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $23,834 - $29,578
106 New
106 $29,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $691B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Leverty Financial Group, LLC Portfolio

Follow Leverty Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leverty Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leverty Financial Group, LLC with notifications on news.